Definitive Contract HHSN272201700004C

Ended Awarded Last action

Contract number
HHSN272201700004C
Awardee
Awarding agency
Obligated
$135,144,719

Award facts

Opportunity
Contract value 97% obligated
  • $135,144,719.22 Current, with exercised options
  • $139,861,060.22 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Cape Fear, NC 28401, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00016 -$858,703
Funding Only Action P00015 -$8,119,900
Funding Only Action P00014 -$1,631,091
Funding Only Action P00013 -$391,094
Exercise an Option P00012 $23,016,018
Exercise an Option P00011 $912,600
Exercise an Option P00010 $22,525,509
Other Administrative Action P00009 · Niaid clinical site monitoring $0
Exercise an Option P00008 $22,045,759
Other Administrative Action P00007 $0
Exercise an Option P00006 $877,751
Exercise an Option P00005 $21,576,599
Additional Work (new agreement, FAR part 6 applies) P00004 · The purpose of this contract is to provide research and development activities related to comprehensive clinical site and study monitoring services for the… $21,978,546
Exercise an Option 3 $17,182,271
Other Administrative Action 2 $0
Exercise an Option 1 $827,962
Original award Niaid clinical site monitoring $15,202,492
Show all 17

About this award

This is a federal contract award to PPD Development LP, a global contract research organization and subsidiary of Thermo Fisher Scientific, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The contract, valued at $139,861,060.22, is for NIAID Clinical Site Monitoring services. This is a definitive contract with a cost-plus-fixed-fee pricing type, with a period of performance through January 31, 2024. The contract is not designated as a set-aside. PPD Development LP has established itself as a critical partner for federal medical research initiatives, supporting agencies like NIAID, the Department of Defense, and the Department of Health and Human Services through prime contracts and subcontracts. The company has a wide range of capabilities, including clinical trial management, regulatory affairs support, laboratory services, data management, and specialized research and development activities across multiple therapeutic areas.

Quick answers

Who was awarded contract HHSN272201700004C?

HHSN272201700004C was awarded to PPD Development LP by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on January 31, 2017.

How much is contract HHSN272201700004C worth?

The government has obligated $135,144,719 on HHSN272201700004C. Its potential value, with all options, is $139,861,060.

Was contract HHSN272201700004C competed?

The extent of competition for HHSN272201700004C was full and open competition. The government received 4 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award